Lijun Suo

561 total citations
18 papers, 160 citations indexed

About

Lijun Suo is a scholar working on Epidemiology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Lijun Suo has authored 18 papers receiving a total of 160 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 8 papers in Molecular Biology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Lijun Suo's work include Pneumonia and Respiratory Infections (5 papers), Gut microbiota and health (5 papers) and Respiratory viral infections research (4 papers). Lijun Suo is often cited by papers focused on Pneumonia and Respiratory Infections (5 papers), Gut microbiota and health (5 papers) and Respiratory viral infections research (4 papers). Lijun Suo collaborates with scholars based in China, United Kingdom and United States. Lijun Suo's co-authors include Xiaokun Shen, Yanan Ji, Li‐Xin Qiu, Yong Song, Li Yu, Ping Zhan, Qian Qian, Xinqing Lin, Yige Li and Bo Liu and has published in prestigious journals such as PLoS ONE, European Journal of Cancer and Signal Transduction and Targeted Therapy.

In The Last Decade

Lijun Suo

14 papers receiving 159 citations

Peers

Lijun Suo
Yasuo Takiguchi Japan
Oluwasina Folawiyo United States
Elizabeth C. Cates Canada
Fahcina Lawson United States
Andrew E. Schriefer United States
Andrea Y. Delgado Medrano United States
Heike E. F. Becker Netherlands
Sterling Wu United States
Kristie L. Hilliard United States
Yasuo Takiguchi Japan
Lijun Suo
Citations per year, relative to Lijun Suo Lijun Suo (= 1×) peers Yasuo Takiguchi

Countries citing papers authored by Lijun Suo

Since Specialization
Citations

This map shows the geographic impact of Lijun Suo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lijun Suo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lijun Suo more than expected).

Fields of papers citing papers by Lijun Suo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lijun Suo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lijun Suo. The network helps show where Lijun Suo may publish in the future.

Co-authorship network of co-authors of Lijun Suo

This figure shows the co-authorship network connecting the top 25 collaborators of Lijun Suo. A scholar is included among the top collaborators of Lijun Suo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lijun Suo. Lijun Suo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Suo, Lijun, et al.. (2025). Altered gut microbiota and metabolite profiles in community-acquired pneumonia: a metagenomic and metabolomic study. Microbiology Spectrum. 13(4). e0263924–e0263924. 2 indexed citations
2.
3.
Zou, X., Liang Hong, Lijun Suo, et al.. (2025). Enrichment of Streptococcus oralis in respiratory microbiome enhance innate immunity and protects against influenza infection. Signal Transduction and Targeted Therapy. 10(1). 272–272.
4.
5.
Yu, Xiaofeng, Lijun Suo, Li Wang, et al.. (2024). Analysis of clinical characteristics and mortality risk factors in patients with community-acquired pneumonia caused by Klebsiella pneumoniae. Diagnostic Microbiology and Infectious Disease. 111(3). 116660–116660.
6.
Suo, Lijun, et al.. (2024). Analyzing lung cancer risks in patients with impaired pulmonary function through characterization of gut microbiome and metabolites. BMC Pulmonary Medicine. 24(1). 1–1. 4 indexed citations
7.
Huang, Lixue, Xiaoying Gu, Yeming Wang, et al.. (2024). Procalcitonin-guided use of antibiotic in hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease: a randomized clinical trial. Clinical Microbiology and Infection. 31(5). 785–792. 2 indexed citations
8.
Han, Xiudi, Liang Chen, Hui Li, et al.. (2022). Prognostic Factors for Cardiovascular Events in Elderly Patients with Community Acquired Pneumonia: Results from the CAP-China Network. Clinical Interventions in Aging. Volume 17. 603–614. 2 indexed citations
9.
Suo, Lijun, et al.. (2022). Myelitis: A Common Complication of Tuberculous Meningitis Predicting Poor Outcome. Frontiers in Neurology. 13. 830029–830029. 8 indexed citations
10.
Liu, Bo, Yige Li, Lijun Suo, et al.. (2022). Characterizing microbiota and metabolomics analysis to identify candidate biomarkers in lung cancer. Frontiers in Oncology. 12. 1058436–1058436. 14 indexed citations
11.
Zou, Xiaohui, Lijun Suo, Yimin Wang, et al.. (2022). Concurrent pigeon paramyxovirus-1 and Acinetobacter baumannii infection in a fatal case of pneumonia. Emerging Microbes & Infections. 11(1). 968–977. 7 indexed citations
12.
Han, Xiudi, Liang Chen, Yimin Wang, et al.. (2021). Cost Effectiveness of Different Initial Antimicrobial Regimens for Elderly Community-Acquired Pneumonia Patients in General Ward. Infection and Drug Resistance. Volume 14. 1845–1853. 4 indexed citations
13.
Suo, Lijun, Xiaofeng Yu, Yongfeng Hu, et al.. (2021). Sirolimus combined with oseltamivir and corticosteroid treatment for a puerpera with severe pneumonia caused by 2009 pandemic H1N1: A case report. Biosafety and Health. 3(6). 343–350. 1 indexed citations
14.
Yu, Xiaofeng, et al.. (2019). Analysis of clinical features of patients infected with influenza A virus in a district hospital. 33(2). 166–170. 1 indexed citations
15.
Zhou, Fuling, Xiqian Xing, Xiudi Han, et al.. (2018). [Clinical characteristics and prognosis of long-term glucocorticoid users with community-acquired pneumonia].. PubMed. 98(10). 738–743. 2 indexed citations
16.
Ji, Yanan, et al.. (2012). CYP1A1 MspI polymorphisms and lung cancer risk: An updated meta-analysis involving 20,209 subjects. Cytokine. 59(2). 324–334. 15 indexed citations
17.
18.
Zhan, Ping, Lijun Suo, Qian Qian, et al.. (2010). Chlamydia pneumoniae infection and lung cancer risk: A meta-analysis. European Journal of Cancer. 47(5). 742–747. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yasuo Takiguchi Breakdown of academic impact, for papers by Oluwasina Folawiyo Breakdown of academic impact, for papers by Elizabeth C. Cates Breakdown of academic impact, for papers by Fahcina Lawson Breakdown of academic impact, for papers by Andrew E. Schriefer Breakdown of academic impact, for papers by Andrea Y. Delgado Medrano Breakdown of academic impact, for papers by Heike E. F. Becker Breakdown of academic impact, for papers by Sterling Wu Breakdown of academic impact, for papers by Kristie L. Hilliard
Rankless by CCL
2026